GRAFT-VERSUS-HOST DISEASE (GVHD)
Clinical trials for GRAFT-VERSUS-HOST DISEASE (GVHD) explained in plain language.
Never miss a new study
Get alerted when new GRAFT-VERSUS-HOST DISEASE (GVHD) trials appear
Sign up with your email to follow new studies for GRAFT-VERSUS-HOST DISEASE (GVHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fish oil infusions tested to tame transplant complication
Disease control ENROLLING_BY_INVITATIONThis study tests whether daily intravenous omega-3 fatty acids (fish oil) can reduce the risk and severity of acute graft-versus-host disease (aGVHD) in 30 adults receiving a stem cell transplant. Participants get omega-3 infusions from before transplant until about 35 days after…
Matched conditions: GRAFT-VERSUS-HOST DISEASE (GVHD)
Phase: PHASE1, PHASE2 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Withdrawn trial sought to protect gut cells in GVHD patients
Disease control TerminatedThis early-phase trial aimed to test whether adding the drug 5-azacytidine (AZA) to standard steroid treatment could protect gut stem cells in patients with gastrointestinal graft-versus-host disease (GVHD), a serious complication after a donor stem cell transplant. The study pla…
Matched conditions: GRAFT-VERSUS-HOST DISEASE (GVHD)
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC